Skip to the main content.

Next-generation therapies demand a next-generation R&D partner.

The Innovation CRO advantage of Veranex is purpose-built to overcome the unique challenges of combination products, drug delivery systems, and companion diagnostics. We solution-engineer with you to power your product from concept through commercialization.

Move vision to velocity. Turn risks into results. Deliver measurable patient impact.

Clinical trials demand more than data collection.

They require disciplined execution that transforms site information into evidence regulators trust. Veranex powers some of the industry’s biggest CROs and biopharma sponsors, translating site data into compelling, accurate, submission-ready evidence from Phases I–IV.

Clean data. Clear insights. Confident submissions.

Veranex Biopharma represents our dedicated focus on advancing new therapies, diagnostics, and delivery systems for biopharma innovators.

Behind every breakthrough is the full force of Veranex, the Innovation CRO built to bridge visionary science and market reality with proven expertise, agile execution, and an unwavering commitment to patient impact.

One company. Full integration. Biopharma breakthroughs accelerated.

From Idea to Impact: Combination Product Innovation

Only the Innovation CRO can align every step to bring your combination product to market with confidence.

35
+

Years of Medtech Design and Engineering

1000
+

Development programs delivered globally

100
%

FDA-registered and ISO 13485 certified facilities

96
%

FDA clearance rate 

for cardiovascular devices

Why Trust Us

Combination Product Expertise Across the Lifecycle Continuum

Combination products face strict oversight. Veranex reduces risk with early alignment of drug and device development with integrated Medtech focus and expertise.

Comprehensive Combination Development Services

From early feasibility to commercialization, we align drug and device pathways to accelerate success.

Strategic Combination Product Planning

For a combination product, clarity on regulatory classification, development strategy, market opportunity, and business needs are all critical to saving years or significant costs and successfully getting to market.

Key Services & Deliverables:

  • Regulatory pathway definition (drug-led, device-led, or co-developed)
  • CE Mark regulatory strategy under EU MDR/IVDR
  • Market and payer landscape assessment
  • Early business case modeling and value proposition development
  • User informed opportunity definitions to inform concept generations
  • Integrated clinical, regulatory, and market strategy planning
combo-product-new-0

Development Services for a Reliable Design

Our integrated teams with quality, engineering, manufacturing, and human factors de-risk your product throughout development to ensure the design is reliable, effective, and safe.

Key Services & Deliverables:

  • Human-centered design for auto-injectors, inhalers, infusion systems, and implants
  • Material compatibility testing to protect drug stability
  • Industrial and digital design for packaging, labeling, and user interfaces
  • Human factor engineers informing usable designs for successful formative and summative studies.
  • Development of Instructions for Use (IFU) and training programs
  • Controlled engineering or V&V builds
2-combo

Preclinical Combination Product Services

Our preclinical teams utilize their depth of experience and existing test models for your combination product testing to ensure safety is demonstrated prior to entering human studies.  

Key Services & Deliverables: 

  • GLP-compliant animal studies evaluating delivery accuracy and device safety 
  • Histopathology for tissue/device interactions and systemic safety 
  • Biocompatibility and toxicology testing aligned to ISO 10993 standards 
  • Bridging studies that connect drug performance with device mechanics 
  • Preclinical reports prepared for FDA and Notified Body submissions
3-combo

Clinical Strategy & Post-Market Surveillance

Clinical trials for combination products are more complex because they must address both drug performance and device usability. Careful trial design accelerates regulatory approval and payer acceptance.

Key Services & Deliverables:

  • Clinical strategy integrating FDA and Notified Body expectations for drug-device studies
  • Study designs aligned to ISO 14155 standards
  • Safety reporting that includes pharmacovigilance and device vigilance
  • Post-market surveillance strategies
4-combo

Regulatory & Quality Consulting and Support

Our team works with drug sponsors to define the regulatory and quality strategy for the device component and continues collaborating with the device partner through submission and launch.

Key Services & Deliverables:

  • QMS harmonization across ISO 13485 and US QMSR
  • FDA submissions including IDE, PMA, 510(k), and De Novo
  • EU pathway execution, including alignment with notified bodies through structured dialogue
  • Integrated risk management under ISO 14971
  • Preparation of design history files and technical documentation
  • EU, Swiss, and UK Authorized Representative services for non-EU manufacturers
5-combo
combo-product-new-1

Manufacturing & Scale-Up for Your Combination Product

Without robust design-for-manufacturing and process validation, timelines and budgets are at risk. Our experienced teams collaborate to ensure the transition from pilot to commercial production is successful.

Key Services & Deliverables:

  • Design-for-manufacturing to ensure scalability and compliance
  • Clinical supply builds in ISO Class 7 and 8 cleanrooms
  • Process validation for sterilization, assembly, and packaging
  • Stability and shelf-life testing across the supply chain
  • Device-focused supply chain management with FDA-registered and ISO 13485-certified facilities
  • Technology transfer planning to manufacturing at scale

Commercial & Market Access

Regulatory approval is not the finish line. Market adoption depends on demonstrating value to patients, providers, and payers with evidence that supports pricing, coding, and reimbursement.

Key Services & Deliverables:

  • Health economics and outcomes research (HEOR) linking drug efficacy with device usability
  • Reimbursement strategy including CPT, J-code, and DRG planning
  • Global market access roadmaps across 30+ countries
  • Value dossiers that integrate clinical and economic outcomes
  • Post-market evidence generation through registries, real-world data, adherence tracking, and PMCF/PSUR obligations under the MDR
combo-product-new-2
wheel-Oct-03-2025-02-06-50-9626-PM

Not every CRO is
built for innovation.
Veranex is.

Scale from molecule to market, including the device.
Your therapy may require delivery, monitoring, or a diagnostic. We build and de-risk those solutions.

  • Concept development through clinical-ready builds
  • Device-specific regulatory, preclinical, and clinical
  • Commercial strategy and market access

All integrated into one team aligned to your goals.

Meet Our Team

Cross-disciplinary experts dedicated to bringing your combination product to market.

Case Studies

From Complexity to Clarity in Combination Product Development

Results that show how integrated expertise delivers first-time-right results.

v

Bring Your Combination Product to Market with Confidence

Partner with Veranex for integrated expertise that reduces risk, accelerates FDA clearance, and ensures commercial adoption.